|
KATNAL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.200400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.630200E-01 |
| Normal-vs-Stage2 |
1.035850E-02 |
| Normal-vs-Stage3 |
3.652000E-02 |
| Normal-vs-Stage4 |
2.892000E-02 |
| Stage1-vs-Stage2 |
1.352440E-01 |
| Stage1-vs-Stage3 |
3.725200E-01 |
| Stage1-vs-Stage4 |
2.728600E-01 |
| Stage2-vs-Stage3 |
3.954400E-01 |
| Stage2-vs-Stage4 |
5.514600E-01 |
| Stage3-vs-Stage4 |
8.164200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.718400E-02 |
| Normal-vs-AfricanAmerican |
7.633800E-01 |
| Normal-vs-Asian |
7.753900E-02 |
| Caucasian-vs-AfricanAmerican |
3.420000E-01 |
| Caucasian-vs-Asian |
8.430600E-01 |
| AfricanAmerican-vs-Asian |
3.058800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.061500E-03 |
| Normal-vs-Female |
1.162430E-01 |
| Male-vs-Female |
1.197610E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.619800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.660200E-02 |
| Normal-vs-Age(61-80Yrs) |
6.084400E-03 |
| Normal-vs-Age(81-100Yrs) |
6.278200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.467200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.830100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.396800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.456600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.719800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.237400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.851200E-01 |
| Classical-VS-Follicular |
4.979400E-04 |
| Classical-VS-Other |
6.705800E-01 |
| Classical-VS-Normal |
2.148600E-01 |
| Tall-VS-Follicular |
4.364300E-02 |
| Tall-VS-Other |
7.010200E-01 |
| Tall-VS-Normal |
4.559600E-01 |
| Follicular-VS-Other |
3.433800E-01 |
| Follicular-VS-Normal |
1.283310E-03 |
| Other-VS-Normal |
8.508400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.321820E-02 |
| Normal-vs-N1 |
4.837600E-02 |
| N0-vs-N1 |
6.225000E-01 |
|
|
